Results
1 -
10 of
26Zhang J.-Z., Ward K. W..
Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-inflammatory cytokines in human THP-1 monocytes, Journal of Antimicrobial Chemotherapy, 2007 Bacterial Topoisomerase Inhibitors: Quinolones and Beyond, Antimicrobials UHPLC Determination of Besifloxacin Enantiomers on Immobilized Amylose Tris(3,5-dichlorophenylcarbamate) Chiral Stationary Phase, Chromatographia Microbiological Etiology and Susceptibility of Bacterial Conjunctivitis Isolates from Clinical Trials with Ophthalmic, Twice-Daily Besifloxacin, Advances in Therapy Besifloxacin Ophthalmic Suspension, 0.6%: a Novel Topical Fluoroquinolone for Bacterial Conjunctivitis, Advances in Therapy Gold nanoparticle-based paper sensor for ultrasensitive and multiple detection of 32 (fluoro)quinolones by one monoclonal antibody, Nano Research New Developments in Antibacterial Chemotherapy for Bacterial Keratitis, Corneal Disease Besifloxacin: Efficacy and Safety in Treatment and Prevention of Ocular Bacterial Infections, Ophthalmology and Therapy Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates, Drugs in R&D